Zynyz 50881-0006-03
Generic: Retifanlimab-Dlwr
- Manufacturer
- Incyte Corporation
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 22, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761334
Need to source Zynyz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Retifanlimab | 25 mg/mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Selected Package
50881-0006-03Selected1 VIAL, SINGLE-USE in 1 CARTON (50881-006-03) / 20 mL in 1 VIAL, SINGLE-USE